Patent · US Active

Compositions useful as inhibitors of protein kinases

US7863282B2 · kind B2 · utility

16Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 15, 2006
Grant dateJan 4, 2011
Priority date—
Expiry dateJun 11, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of formula Ia:or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.